• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Pathology of transitional cell carcinoma of the bladder and its clinical implications.

作者信息

Lapham R L, Ro J Y, Staerkel G A, Ayala A G

机构信息

Department of Pathology, University of Texas M. D. Anderson Cancer Center, Houston 77030, USA.

出版信息

Semin Surg Oncol. 1997 Sep-Oct;13(5):307-18. doi: 10.1002/(sici)1098-2388(199709/10)13:5<307::aid-ssu4>3.0.co;2-h.

DOI:10.1002/(sici)1098-2388(199709/10)13:5<307::aid-ssu4>3.0.co;2-h
PMID:9259086
Abstract

Transitional cell carcinomas are divided into superficial and muscle-invasive tumors. Most of them are superficial tumors, and approximately 15-20% are muscle-invasive carcinomas. Pathologists play a significant role in diagnosing bladder tumors and in reporting features important for determining prognosis. We will review the cytologic and histopathologic features that help determine prognosis, including depth of invasion, tumor grade, multicentricity, tumor size, and the presence of vascular/lymphatic invasion, blood group antigen expression, proliferative indices, and molecular markers. Brief mention will be made of specimen handling, interpretation, reporting, and histologic variants of transitional cell carcinoma.

摘要

相似文献

1
Pathology of transitional cell carcinoma of the bladder and its clinical implications.
Semin Surg Oncol. 1997 Sep-Oct;13(5):307-18. doi: 10.1002/(sici)1098-2388(199709/10)13:5<307::aid-ssu4>3.0.co;2-h.
2
Pathologic prognostic parameters in bladder urothelial biopsy, transurethral resection, and cystectomy specimens.膀胱尿路上皮活检、经尿道切除术及膀胱切除术标本中的病理预后参数。
Semin Diagn Pathol. 1997 May;14(2):109-22.
3
Cytologic and histologic features of superficial bladder cancer.
Urol Clin North Am. 1992 Aug;19(3):435-53.
4
Invasion of the bladder by transitional cell carcinoma: its relation to histologic grade and expression of p53, MIB-1, c-erb B-2, epidermal growth factor receptor, and bcl-2.移行细胞癌侵犯膀胱:其与组织学分级以及p53、MIB-1、c-erb B-2、表皮生长因子受体和bcl-2表达的关系。
Cancer. 1998 Feb 15;82(4):715-23. doi: 10.1002/(sici)1097-0142(19980215)82:4<715::aid-cncr15>3.0.co;2-0.
5
Prognostic factors in T1 bladder urothelial carcinoma: the value of recording millimetric depth of invasion, diameter of invasive carcinoma, and muscularis mucosa invasion.T1 期膀胱尿路上皮癌的预后因素:记录浸润毫米深度、浸润性癌直径和黏膜肌层浸润的价值。
Hum Pathol. 2013 Jan;44(1):95-102. doi: 10.1016/j.humpath.2012.04.020. Epub 2012 Aug 30.
6
Diagnosis, staging, and classification of bladder tumors.膀胱肿瘤的诊断、分期及分类
Semin Urol. 1983 Feb;1(1):7-14.
7
Incidence of apoptosis, cell proliferation and bcl-2 expression in transitional cell carcinoma of the bladder: association with tumor progression.膀胱移行细胞癌中细胞凋亡、细胞增殖及bcl-2表达的发生率:与肿瘤进展的关联
J Urol. 1996 Jan;155(1):316-20.
8
Bladder cancer: natural history, tumor markers, and early detection strategies.
Semin Surg Oncol. 1997 Sep-Oct;13(5):299-306. doi: 10.1002/(sici)1098-2388(199709/10)13:5<299::aid-ssu3>3.0.co;2-8.
9
[Bladder tumor histo-seminar - case 6: Invasive urothelial carcinoma, with inverted growth (UroA/FGFR3 molecular type)].[膀胱肿瘤组织学研讨会 - 病例6:浸润性尿路上皮癌,呈内翻性生长(UroA/FGFR3分子类型)]
Ann Pathol. 2016 Dec;36(6):394-397. doi: 10.1016/j.annpat.2016.09.010. Epub 2016 Nov 9.
10
Lymphovascular invasion and the presence of more than three tumors are associated with poor outcomes of muscle-invasive bladder cancer after bladder-conserving therapies.脉管侵犯和肿瘤数目超过 3 个与膀胱保留治疗后肌层浸润性膀胱癌的不良预后相关。
Urology. 2010 Oct;76(4):902-7. doi: 10.1016/j.urology.2010.05.007. Epub 2010 Aug 14.

引用本文的文献

1
CD73 Predicts Favorable Prognosis in Patients with Nonmuscle-Invasive Urothelial Bladder Cancer.CD73可预测非肌层浸润性尿路上皮膀胱癌患者的良好预后。
Dis Markers. 2015;2015:785461. doi: 10.1155/2015/785461. Epub 2015 Oct 12.
2
Expectant Management of Low-Risk Bladder Cancer.低风险膀胱癌的期待性管理
Curr Urol Rep. 2015 Dec;16(12):82. doi: 10.1007/s11934-015-0555-1.
3
Connexin 43 expression predicts poor progression-free survival in patients with non-muscle invasive urothelial bladder cancer.连接蛋白43的表达预示着非肌层浸润性尿路上皮膀胱癌患者无进展生存期较差。
J Clin Pathol. 2015 Oct;68(10):819-24. doi: 10.1136/jclinpath-2015-202898. Epub 2015 Aug 6.
4
Predictive and Prognostic Value of Ribonucleotide Reductase Regulatory Subunit M1 and Excision Repair Cross-Complementation Group 1 in Advanced Urothelial Carcinoma (UC) Treated with First-Line Gemcitabine Plus Platinum Combination Chemotherapy.核糖核苷酸还原酶调节亚基M1和切除修复交叉互补组1在一线吉西他滨联合铂类化疗的晚期尿路上皮癌(UC)中的预测和预后价值
PLoS One. 2015 Jul 22;10(7):e0133371. doi: 10.1371/journal.pone.0133371. eCollection 2015.
5
Expression of histone deacetylases 1, 2 and 3 in urothelial bladder cancer.组蛋白去乙酰化酶1、2和3在膀胱尿路上皮癌中的表达
BMC Clin Pathol. 2014 Mar 13;14(1):10. doi: 10.1186/1472-6890-14-10.
6
Plasma human neutrophil proteins-1, -2, and -3 levels in patients with bladder cancer.膀胱癌患者血浆中性粒细胞蛋白-1、-2 和-3 水平。
J Cancer Res Clin Oncol. 2013 Feb;139(2):195-9. doi: 10.1007/s00432-012-1305-0. Epub 2012 Sep 26.
7
Inhibition of bladder cancer development by allyl isothiocyanate.丙烯基异硫氰酸酯抑制膀胱癌的发展。
Carcinogenesis. 2010 Feb;31(2):281-6. doi: 10.1093/carcin/bgp303. Epub 2009 Dec 2.
8
Highly invasive transitional cell carcinoma of the bladder in a simian virus 40 T-antigen transgenic mouse model.猿猴病毒40 T抗原转基因小鼠模型中的高侵袭性膀胱移行细胞癌
Am J Pathol. 2000 Sep;157(3):805-13. doi: 10.1016/S0002-9440(10)64594-4.
9
The association between CD2+ peripheral blood lymphocyte subsets and the relapse of bladder cancer in prophylactically BCG-treated patients.卡介苗预防性治疗患者中CD2 +外周血淋巴细胞亚群与膀胱癌复发之间的关联。
Br J Cancer. 1999 Mar;79(7-8):1162-7. doi: 10.1038/sj.bjc.6690185.